Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-27T04:53:39.972Z Has data issue: false hasContentIssue false
  • English
  • Français

Improvement of social phobic symptoms after treatment with brofaromine, a reversible and selective inhibitor of MAO-A

Published online by Cambridge University Press:  16 April 2020

D Garcia-Borreguero  and
T Bronisch
D Garcia-Borreguero*
Affiliation:
Max-Planck-lnstitute of Psychiatry, Kraepelinstraβe, 10, 8000, Munich40, Germany
T Bronisch
Affiliation:
Max-Planck-lnstitute of Psychiatry, Kraepelinstraβe, 10, 8000, Munich40, Germany
*
*Present address: National Institute of Mental Health, Bld 10/Room 4S-239, 9000 Rockville Pike, Bethesda, MD 20892, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
European Psychiatry , Volume 7 , Issue 2 , 1992 , pp. 93 - 94
Copyright
Copyright © Elsevier, Paris 1992

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM III-R) 3rd edn revised. American Psychiatric Press, Washington, DCGoogle Scholar
Cooper, AJ (1989) Tyramine and irreversible monoamine oxidase inhibitors in clinical practice Br J Psychiatry (suppl 6) 155, 38–45CrossRefGoogle Scholar
Levin, APSchneier, FRLiebowitz, MR (1989) Social phobia: biology and pharmacology Clin Psychol Rev 9, 129–140CrossRefGoogle Scholar
Liebowitz, MRGorman, JMFyer, AJet al (1988) Pharmacotherapy of social phobia: an interim of a placebo-controlled comparison of phenelzine and atenolol J Clin Psychiatry 49, 252–257Google ScholarPubMed
Möller, HJWendt, GWaldmeier, P (1991) Brofaromine - a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings Pharmacopsychiatria (Stuttgart) 24, 50–54CrossRefGoogle ScholarPubMed
Waldmeier, PCBaumann, PAStula-Delini, ABernasconi, RSigg, KBuech, OFelner, AE (1983) Characterization of a new, short-acting and specific inhibitor of type A monoamine oxydase Mod Probl Pharmacopsychiatry 19, 31–52CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.